Introduction

Angelman syndrome is a rare genetic disorder that primarily affects the nervous system. It is estimated that Angelman syndrome disorder usually occurs in one in 12,000 to 20,000 people in the general population. Angelman syndrome is caused by a loss of function in the UBE3A gene on the maternal 15th chromosome. People suffering from Angelman syndrome frequently laugh and smile, and have excitable personalities.

The symptoms of Angelman syndrome include seizures, lack of speech, and balance issues. Other symptoms are tongue thrusting, developmental delays, jerky movements, small head size with flatness in the back of the head, and others. Presently, therapies for Angelman syndrome are supportive and symptomatic. The diagnosis of Angelman syndrome is done through a genetic test, in which a small amount of blood is taken from the patient and sent to a lab for testing. Tests review DNA patterns, gene mutations, and missing chromosomes.

Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1309

Angelman Syndrome Treatment Market: Overview

People suffering from Angelman syndrome generally tend to live a normal life span, but the disorder cannot be cured. Angelman syndrome is caused due to the absence of a functional copy of the UBE3A gene, which is inherited from the mother. It is also estimated that, over the forecast period, the Angelman syndrome treatment market will witness moderate growth. Recently, the U.S. Food and Drug Administration has approved the orphan drug GTX-101 for the treatment of Angelman syndrome. Treatment mainly focuses on managing the medical and developmental issues.

Angelman Syndrome Treatment Market: Segmentation

Tentatively, the global Angelman syndrome treatment market is segmented on the basis of treatment, service provider, and geography.

Based on treatment, the global Angelman syndrome treatment market is segmented as:

• Physical Therapy
• Communication Therapy
• Behavior Therapy
• Others

Based on the service provider, the global Angelman syndrome treatment market is segmented as:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others